{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:02:49Z","timestamp":1790251369418,"version":"4.1.0"},"reference-count":54,"publisher":"BioExcel","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ghimas S.p.A."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"abstract":"<jats:p>Background: Women in perimenopause or postmenopause experience an increased susceptibility to cardiometabolic disorders due to hormonal and physiological changes. This study assessed the effects of a multiingredient nutraceutical formulation (Syndrema\u00ae, Ghimas S.p.A.) on metabolic, inflammatory and anthropometric parameters in at-risk women in perimenopause. The formulation was designed to simultaneously target several components: body fat mass, insulin resistance, dyslipidaemia, glycaemic homeostasis, arterial hypertension and oxidative stress.\n\nMethods: Twenty-four women in perimenopause or postmenopause (aged 45\u201360 years, BMI \u226527) participated in a 90-day prospective, single-arm observational study conducted in a real-life clinical setting. They received the nutraceutical alongside an isocaloric diet and a standardized physical activity regimen. Assessments of clinical, biochemical and body composition parameters were conducted at baseline and at the 90-day follow-up. Evaluations included anthropometrics, bioelectrical impedance analysis, lipid profile, inflammatory and metabolic markers, insulin and glucose levels and haemodynamic variables. Paired t-tests were used to evaluate changes over time.\n\nResults: After 90 days, participants showed significant reductions in body weight, body mass index, waist circumference, systolic blood pressure, low density lipoprotein cholesterol, triglycerides, C-reactive protein, homocysteine and uric acid. Bioelectrical impedance analysis indicated improved body composition with reductions in fat mass and fat mass percentage. Liver enzymes and azotaemia also declined, suggesting systemic benefits.\n\nConclusions: The combination of a multi-ingredient nutraceutical and lifestyle modifications was associated with favourable changes in cardiometabolic, inflammatory and body composition parameters in women in perimenopause and postmenopause. These results support the role of early, non-pharmacological interventions in mitigating cardiometabolic risk during menopause. Further randomized controlled trials are needed to confirm efficacy and long-term outcomes.\n\nDownload the Plain Language Summary of this article: https:\/\/www.drugsincontext.com\/plain-language-summaries\/plain-language-summary-body-composition-and-cardiometabolic-risk-reduction-following-therapy-with-a-multi-ingredient-nutraceutical-formulation-a-real-life-clinical-study<\/jats:p>","DOI":"10.7573\/dic.2025-12-7","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:17:32Z","timestamp":1778753852000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Body composition and cardiometabolic risk reduction following therapy with a multi-ingredient nutraceutical formulation: a real-life clinical study"],"prefix":"10.7573","volume":"15","author":[{"given":"Anna Maria","family":"Sironi","sequence":"first","affiliation":[{"name":"Studio Medico di Dietologia e Diabetologia \u201cAMS\u201d, Marlia (Lucca), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Franchini","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology of the National Research Council of Italy (IFCCNR), Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Tessieri","sequence":"additional","affiliation":[{"name":"Studio Medico di Dietologia e Diabetologia \u201cAMS\u201d, Marlia (Lucca), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Maffei","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/058a2pj71","id-type":"ROR","asserted-by":"publisher"}],"name":"Fondazione Toscana Gabriele Monasterio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1.\tAlessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol. 2006;26(10):2200\u20132207. https:\/\/doi.org\/10.1161\/01.ATV.0000242905.41404.68","DOI":"10.1161\/01.ATV.0000242905.41404.68"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2.\tPalaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens. 2003;16:952\u2013958. https:\/\/doi.org\/10.1016\/s0895-7061(03)01009-4","DOI":"10.1016\/S0895-7061(03)01009-4"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tMahendra JV, Kumar SD, Anuradha TS, Talikoti P, Nagaraj RS, Vishali V. Plasma fibrinogen in type 2 diabetic patients with metabolic syndrome and its relation with ischemic heart disease (IHD) and retinopathy. J Clin Diagn Res. 2015;9(1):BC18\u201321. https:\/\/doi.org\/10.7860\/JCDR\/2015\/10712.5449","DOI":"10.7860\/JCDR\/2015\/10712.5449"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tPuig JG, Mart\u00ednez MA. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol. 2008;20(2):187\u2013191. https:\/\/doi.org\/10.1097\/BOR.0b013e3282f4b1ed","DOI":"10.1097\/BOR.0b013e3282f4b1ed"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.\tJha BK, Sherpa ML, Imran M, et al. Progress in understanding metabolic syndrome and knowledge of its complex pathophysiology. Diabetology. 2023;4(2):134\u2013159. https:\/\/doi.org\/10.3390\/diabetology4020015","DOI":"10.3390\/diabetology4020015"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tSaadi MM, Roy MN, Haque R, Tania FA, Mahmood S, Ali N. Association of microalbuminuria with metabolic syndrome: a cross-sectional study in Bangladesh. BMC Endocr Disord. 2020;20(1):153. https:\/\/doi.org\/10.1186\/s12902 -020-00634-0","DOI":"10.1186\/s12902-020-00634-0"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.\tOnat A, Ozhan H, Erbilen E, et al. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels. Int J Cardiol. 2009;135(2):211\u2013217. https:\/\/doi.org\/10.1016\/j.ijcard.2008.03.054","DOI":"10.1016\/j.ijcard.2008.03.054"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.\tCoffey CS, Asselbergs FW, Hebert PR, et al. The association of the metabolic syndrome with PAI-1 and t-PA levels. Cardiol Res Pract. 2011;2011:541467. https:\/\/doi.org\/10.4061\/2011\/541467","DOI":"10.4061\/2011\/541467"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.\tEslam M, Sanyal AJ, George J; International Consensus Panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999\u20132014.e1. https:\/\/doi.org\/10.1053\/ j.gastro.2019.11.312","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.\tKhan AR, Salama AH, Aleem Z, Alfakeer H, Alnemr L, Shareef AMM. The promising frontier of cardiometabolic syndrome: a new paradigm in cardiology. Cureus. 2023;15(9):e45542. https:\/\/doi.org\/10.7759\/cureus.45542","DOI":"10.7759\/cureus.45542"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.\tGallo G, Savoia C. New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications. Int J Mol Sci. 2024;25(5):2973. https:\/\/doi.org\/10.3390\/ijms25052973","DOI":"10.3390\/ijms25052973"},{"key":"ref11","unstructured":"12.\tChatterjee A, Harris SB, Leiter LA, Fitchett DH, Teoh H, Bhattacharyya OK; Cardiometabolic Risk Working Group (Canadian). Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement. Can Fam Physician. 2012;58(4):389\u2013393, e196\u2013201."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.\tRidker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391\u2013 397. https:\/\/doi.org\/10.1161\/01.cir.0000055014.62083.05","DOI":"10.1161\/01.CIR.0000055014.62083.05"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.\tNishida M, Moriyama T, Ishii K, et al. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta. 2007;384(1\u20132):99\u2013104. https:\/\/doi.org\/10.1016\/j.cca.2007.06.009","DOI":"10.1016\/j.cca.2007.06.009"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.\tIslam MS, Wei P, Suzauddula M, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol Med. 2024;30(1):279. https:\/\/doi.org\/10.1186\/s10020-024-01019-y","DOI":"10.1186\/s10020-024-01019-y"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.\tSverdlov AL, Figtree GA, Horowitz JD, Ngo DTM. Interplay between oxidative stress and inflammation in cardiometabolic syndrome. Mediators Inflamm. 2016;2016:8254590. https:\/\/doi.org\/10.1155\/2016\/8254590","DOI":"10.1155\/2016\/8254590"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17.\tTrouwborst I, Jardon KM, Gijbels A, et al. Body composition and body fat distribution in tissue-specific insulin resistance and in response to a 12-week isocaloric dietary macronutrient intervention. Nutr Metab. 2024;21(1):20. https:\/\/doi.org\/10.1186\/s12986-024-00795-y","DOI":"10.1186\/s12986-024-00795-y"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.\tM\u00fcller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev. 2012;13(Suppl 2):6\u201313. https:\/\/doi.org\/10.1111\/j.1467-789X.2012.01033.x","DOI":"10.1111\/j.1467-789X.2012.01033.x"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.\tB\u00f6hm A, Heitmann BL. The use of bioelectrical impedance analysis for body composition in epidemiological studies. Eur J Clin Nutr. 2013;67(Suppl 1):S79\u201385. https:\/\/doi.org\/10.1038\/ejcn.2012.168","DOI":"10.1038\/ejcn.2012.168"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20.\tda Silva BR, Orsso CE, Gonzalez MC, et al. Phase angle and cellular health: inflammation and oxidative damage. Rev Endocr Metab Disord. 2023;24(3):543\u2013562. https:\/\/doi.org\/10.1007\/s11154-022-09775-0","DOI":"10.1007\/s11154-022-09775-0"},{"key":"ref20","unstructured":"21.\tM\u00e1ttar JA. Application of total body bioimpedance to the critically ill patient. Brazilian group for bioimpedance study. New Horiz. 1996;4(4):493\u2013503."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22.\tZdolsek HJ, Lindahl OA, Sj\u00f6berg F. Non-invasive assessment of fluid volume status in the interstitium after haemodialysis. Physiol Meas. 2000;21(2):211\u2013220. https:\/\/doi.org\/10.1088\/0967-3334\/21\/2\/301","DOI":"10.1088\/0967-3334\/21\/2\/301"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23.\tLovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32(6):949\u2013958. https:\/\/doi.org\/10.1038\/ijo.2008.25","DOI":"10.1038\/ijo.2008.25"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24.\tMarlatt KL, Pitynski-Miller DR, Gavin KM, et al. Body composition and cardiometabolic health across the menopause transition. Obesity. 2022;30(1):14\u201327. https:\/\/doi.org\/10.1002\/oby.23289","DOI":"10.1002\/oby.23289"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25.\tLindquist P, Bengtsson C, Lissner L, Bj\u00f6rkelund C. Cholesterol and triglyceride concentration as risk factors for myocardial infarction and death in women, with special reference to influence of age. J Intern Med. 2002;251(6):484\u2013489. https:\/\/doi.org\/10.1046\/j.1365-2796.2002.00985.x","DOI":"10.1046\/j.1365-2796.2002.00985.x"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.\tCosentino F, Verma S, Ambery P, et al. Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table. Eur Heart J. 2023;44(39):4141\u20134156. https:\/\/doi.org\/10.1093\/eurheartj\/ehad445","DOI":"10.1093\/eurheartj\/ehad445"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27.\tSerna A, Marhuenda J, Arcusa R, et al. Effectiveness of a polyphenolic extract (Lippia citriodora and Hibiscus sabdariffa) on appetite regulation in overweight and obese grade I population: an 8-week randomized, double-blind, cross-over, placebo-controlled trial. Eur J Nutr. 2022;61(2):825\u2013841. https:\/\/doi.org\/10.1007\/s00394-021-02678-x","DOI":"10.1007\/s00394-021-02678-x"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28.\tRahman HA, Sahib NG, Saari N, et al. Anti-obesity effect of ethanolic extract from Cosmos caudatus Kunth leaf in lean rats fed a high fat diet. BMC Complement Altern Med. 2017;17(1):122. https:\/\/doi.org\/10.1186\/s12906-017-1640-4","DOI":"10.1186\/s12906-017-1640-4"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"29.\tMarhuenda J, Perez S, Victoria-Montesinos D, et al. A randomized, double-blind, placebo controlled trial to determine the effectiveness a polyphenolic extract (Hibiscus sabdariffa and Lippia citriodora) in the reduction of body fat mass in healthy subjects. Foods. 2020;9(1):55. https:\/\/doi.org\/10.3390\/foods9010055","DOI":"10.3390\/foods9010055"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30.\tAbdollahi S, Toupchian O, Jayedi A, Meyre D, Tam V, Soltani S. Zinc supplementation and body weight: a systematic review and dose-response meta-analysis of randomized controlled trials. Adv Nutr. 2020;11(2):398\u2013411. https:\/\/doi. org\/10.1093\/advances\/nmz084","DOI":"10.1093\/advances\/nmz084"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"31.\tKucukgoncu S, Zhou E, Lucas KB, Tek C. Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials. Obes Rev. 2017;18(5):594\u2013601. https:\/\/doi.org\/10.1111\/obr.12528","DOI":"10.1111\/obr.12528"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32.\tGossa Al-Saadde DL, Haider AM, Ali A, et al. The role of chromium supplementation in cardiovascular risk factors: a comprehensive reviews of putative molecular mechanisms. Heliyon. 2023;9(9):e19826. https:\/\/doi.org\/10.1016\/ j.heliyon.2023.e19826","DOI":"10.1016\/j.heliyon.2023.e19826"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"33.\tHenry-Vitrac C, Ibarra A, Roller M, M\u00e9rillon J-M, Vitrac X. Contribution of chlorogenic acids to the inhibition of human hepatic glucose-6-phosphatase activity in vitro by Svetol, a standardized decaffeinated green coffee extract. J Agric Food Chem. 2010;58(7):4141\u20134144. https:\/\/doi.org\/10.1021\/jf9044827","DOI":"10.1021\/jf9044827"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"34.\tFlanagan J, Bily A, Rolland Y, Roller M. Lipolytic activity of svetol\u00ae, a decaffeinated green coffee bean extract. Phytother Res. 2014;28(6):946\u2013948. https:\/\/doi.org\/10.1002\/ptr.5085","DOI":"10.1002\/ptr.5085"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"35.\tRamos JGM, Pairazam\u00e1n ATE, Willis MESM, Santisteban SC, Herrera EC. Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review. F1000Res. 2021;10:1022. https:\/\/doi.org\/10.12688\/ f1000research.55573.1","DOI":"10.12688\/f1000research.55573.1"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"36.\tHajizadeh-Sharafabad F, Moludi J, Tutunchi H, Taheri E, Izadi A, Maleki V. Selenium and polycystic ovary syndrome; current knowledge and future directions: a systematic review. Horm Metab Res. 2019;51(5):279\u2013287. https:\/\/doi. org\/10.1055\/a-0890-6823","DOI":"10.1055\/a-0890-6823"},{"key":"ref36","unstructured":"37.\tRondanelli M, Opizzi A, Faliva M, Bucci M, Perna S. Relationship between the absorption of 5-hydroxytryptophan from an integrated diet, by means of Griffonia simplicifolia extract, and the effect on satiety in overweight females after oral spray administration. Eat Weight Disord. 2012;17(1):e22\u2013e28. https:\/\/doi.org\/10.3275\/8165"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"38.\tHaskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423\u2013 1434. https:\/\/doi.org\/10.1249\/mss.0b013e3180616b27","DOI":"10.1249\/mss.0b013e3180616b27"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"39.\tShai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359(3):229\u2013241. https:\/\/doi.org\/10.1056\/NEJMoa0708681","DOI":"10.1056\/NEJMoa0708681"},{"key":"ref39","unstructured":"40.\tMarfell-Jones M, Olds T, Stewart A, Carter L. International Standards for Anthropometric Assessment. The International Society for the Advancement of Kim Anthropometric (ISAK), Potchefsroom, South Africa. 2026. https:\/\/ researchportal.vub.be\/en\/publications\/international-standards-for-anthropometric-assessment-2006\/"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"41.\tNishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO expert consultation on waist circumference and waist-hip ratio. Eur J Clin Nutr. 2010;64(1):2\u20135. https:\/\/doi.org\/10.1038\/ejcn.2009.139","DOI":"10.1038\/ejcn.2009.139"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"42.\tBioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment conference statement. Am J Clin Nutr. 1996;64(3 Suppl):524S\u2013532S. https:\/\/doi.org\/10.1093\/ ajcn\/64.3.524S","DOI":"10.1093\/ajcn\/64.3.524S"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"43.\tBarrea L, Altieri B, Muscogiuri G, et al. Impact of nutritional status on gastroenteropancreatic neuroendocrine tumors (GEP-NET) aggressiveness. Nutrients. 2018;10(12):1854. https:\/\/doi.org\/10.3390\/nu10121854","DOI":"10.3390\/nu10121854"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"44.\tKyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430\u201353. https:\/\/doi.org\/10.1016\/j.clnu.2004.09.012","DOI":"10.1016\/j.clnu.2004.09.012"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"45.\tKushner RF. Bioelectrical impedance analysis: a review of principles and applications. J Am Coll Nutr. 1992;11(2):199\u2013 209. https:\/\/doi.org\/10.1080\/07315724.1992.12098245","DOI":"10.1080\/07315724.1992.12098245"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"46.\tSiripuram C, Gunde AK, Hegde SV, Ghetia KS, Kandimalla R. Exploring cardiovascular health: the role of dyslipidemia and inflammation. Cureus. 2025;17(2):e78818. https:\/\/doi.org\/10.7759\/cureus.78818","DOI":"10.7759\/cureus.78818"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"47.\tJamilian M, Foroozanfard F, Bahmani F, Talaee R, Monavari M, Asemi Z. Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. 2016;170(2):271\u2013278. https:\/\/doi.org\/10.1007\/s12011-015-0480-7","DOI":"10.1007\/s12011-015-0480-7"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"48.\tAbramson JL, Hooper WC, Jones DP, et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis. 2005;178(1):115\u2013121. https:\/\/doi. org\/10.1016\/j.atherosclerosis.2004.08.007","DOI":"10.1016\/j.atherosclerosis.2004.08.007"},{"key":"ref48","unstructured":"49.\tVigna L, Solimena G, Bamonti F, et al. Effects of 1-month R-\u03b1-lipoic acid supplementation on humans oxidative status: a pilot study. Progress Nutr. 2017;19:14\u201325. https:\/\/doi.org\/10.23751\/pn.v19i1.6325"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"50.\tMeng ZQ, Tang ZH, Yan YX, et al. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation. Am J Chin Med. 2014;42(6):1471\u2013183. https:\/\/doi.org\/10.1142\/ S0192415X1450092X","DOI":"10.1142\/S0192415X1450092X"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"51.\tGonz\u00e1lez S, Huerta JM, Alvarez-Ur\u00eda J, Fern\u00e1ndez S, Patterson AM, Lasheras C. Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr. 2004;134(7):1736\u20131740. https:\/\/doi.org\/10.1093\/ jn\/134.7.1736","DOI":"10.1093\/jn\/134.7.1736"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"52.\tStonehouse W, Benassi-Evans B, Louise J. The effects of a novel nutraceutical combination on low-density lipoprotein cholesterol and other markers of cardiometabolic health in adults with hypercholesterolaemia: a randomised double-blind placebo-controlled trial. Atherosclerosis. 2025;403:119177. https:\/\/doi.org\/10.1016\/ j.atherosclerosis.2025.119177","DOI":"10.1016\/j.atherosclerosis.2025.119177"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"53.\tPacella D, Lembo M, Trimarco V, et al. Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial. Cardiovasc Diabetol. 2025;24(1):384. https:\/\/doi.org\/10.1186\/s12933-025-02920-4","DOI":"10.1186\/s12933-025-02920-4"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"54.\tCosta PCT, de Luna Freire MO, de Oliveira Coutinho D, et al. Nutraceuticals in the management of autonomic function and related disorders: a comprehensive review. Pharmacol Res. 2024;208:107368. https:\/\/doi.org\/10.1016\/ j.phrs.2024.107368","DOI":"10.1016\/j.phrs.2024.107368"}],"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2026\/05\/dic.2025-12-7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:00:08Z","timestamp":1790247608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/body-composition-and-cardiometabolic-risk-reduction-following-therapy-with-a-multi-ingredient-nutraceutical-formulation-a-real-life-clinical-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7573\/dic.2025-12-7","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"dic.2025-12-7"}}